Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	GLPG1972 75 mg	0	234
Total, all-cause mortality	GLPG1972 150 mg	1	231
Total, all-cause mortality	GLPG1972 300 mg	0	232
Total, all-cause mortality	Placebo	0	234
Total, other adverse events	GLPG1972 75 mg	114	234
Total, other adverse events	GLPG1972 150 mg	124	231
Total, other adverse events	GLPG1972 300 mg	105	232
Total, other adverse events	Placebo	130	234
Total, serious adverse events	GLPG1972 75 mg	17	234
Total, serious adverse events	GLPG1972 150 mg	17	231
Total, serious adverse events	GLPG1972 300 mg	18	232
Total, serious adverse events	Placebo	18	234

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03595618/event-totals